Financial Reports Latest Updates Industry Maps Economic Calendar

uniQure N.V. (QURE) Annual Reports

Q: Where can I read uniQure N.V. (QURE) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

uniQure N.V. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1590560 →

Website：Official site ↗

Financial Highlights

FY2026 Q1 (quarterly, ended 2026-03-31)
	Current	Prior year	YoY
Revenue	$3.6M	$1.6M	+127.3%
Operating income	$-45.7M	$-39.3M	-16.2%
Net income	$-53.5M	$-43.6M	-22.7%
EPS (diluted)	$-0.85	$-0.82	-3.7%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 3.56 mn Net income -53.5 mn

Show table：Income statement

Item	2014Q4	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
Revenue	6.14	10.6	4.30	4.45	7.22	9.13	3.32	4.94	2.26	2.58	3.48	3.05	3.15	1.61	1.14	2.47	1.05	2.63	0.1	1.54	1.79	34.1	0.45	464	1.99	57.7	1.79	0.5	1.45	103	5.33	2.42	1.41	6.69	8.49	11.1	2.29	5.22	1.57	5.26	3.70	5.57	3.56
Operating income	-53.7	-71.2	-19.3	-22.1	-14.2	-16.4	-19.7	-19.7	-9.27	-22.6	-19.6	-21.2	-23.2	-24.2	-27.5	-29.3	-31.3	-33.0	-34.5	-38.2	-44.5	-8.26	-44.5	398	-45.0	2.07	-54.1	-56.1	-59.5	26.5	-74.2	-65.1	-81.9	-61.8	-54.2	-44.0	-40.2	-45.8	-39.3	-43.9	-51.0	-51.1	-45.7
Net income	—	-82.1	—	—	—	-73.4	-20.3	-21.3	-10.2	-27.5	-18.8	-20.6	-22.0	-21.9	-27.8	-31.4	-23.6	-41.4	-28.0	-42.5	-53.8	-0.7	-41.6	399	-36.5	8.22	-46.7	-39.1	-47.9	6.80	-77.2	-68.5	-89.6	-73.2	-65.6	-56.3	-44.4	-73.3	-43.6	-37.7	-80.5	-37.1	-53.5

Balance sheet

Quarterly · In mn (USD)

Total assets 779 mn Total liabilities 629 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2014Q4	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
Current assets	—	228	—	—	—	144	124	111	92.3	163	145	263	242	237	213	189	408	384	350	320	287	259	282	694	594	628	578	523	465	477	443	757	694	652	596	592	464	390	435	409	716	656	616
Total assets	—	263	—	—	—	190	170	158	139	210	192	309	281	274	269	253	472	449	414	385	351	340	364	784	775	809	757	701	638	705	631	943	872	832	770	731	646	557	605	585	888	825	779
Current liabilities	—	26.9	—	—	—	22.7	20.5	23.1	25.4	19.2	26.6	31.4	32.0	20.0	22.4	23.4	28.4	31.6	27.1	29.8	33.4	27.3	32.1	46.1	41.9	36.8	44.7	48.3	64.0	75.9	66.3	68.4	68.6	73.7	63.5	80.5	71.3	40.0	36.3	40.9	101	62.9	59.2
Total liabilities	—	135	—	—	—	127	124	131	119	120	92.0	90.1	81.2	94.3	112	121	121	126	119	120	123	96.5	135	151	184	213	211	215	217	229	218	589	603	624	623	634	590	563	572	589	660	626	629
Equity	42.6	128	—	—	—	63.6	45.7	27.3	19.6	89.4	100	218	200	180	157	132	350	323	295	266	228	244	229	634	591	596	546	486	421	476	413	353	269	208	147	97.1	55.8	-6.75	33.7	-4.00	229	199	149

Cash flow

Quarterly · In mn (USD)

Operating -38.2 mn Investing 98.6 mn Financing 0.55 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2014Q4	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
Operating	-36.9	7.47	-15.7	-22.7	-18.1	-15.7	-11.7	-19.1	-15.4	-18.1	-21.4	-16.5	-20.1	-18.0	-26.4	-24.2	-22.0	-26.0	-33.0	-30.0	-34.7	-37.2	-41.3	416	-40.2	-47.1	-25.7	-15.7	-49.0	-54.7	-78.3	-57.0	38.9	-49.5	-60.6	-32.7	-36.6	-52.8	-44.1	-39.9	-16.4	-77.6	-38.2
Investing	-23.9	-8.02	-2.47	-1.69	-9.38	-3.62	-1.97	-1.44	-1.53	-0.65	-0.65	-1.99	-0.86	-0.74	-1.23	-1.20	-2.26	-1.96	-2.89	-1.72	-2.18	-2.69	-3.88	-2.31	-57.6	-3.55	-4.88	-4.58	-5.06	-168	2.99	45.8	-314	59.6	64.0	77.9	47.7	-26.6	20.1	73.1	26.6	-441	98.6
Financing	94.4	161	0.77	1.33	-0.03	0.38	0.44	0.5	0.1	89.0	1.56	140	1.64	14.8	2.68	0.54	244	1.31	1.01	2.54	0.14	3.76	62.6	2.51	-0.16	29.9	0.49	0.06	0.3	0.6	0.13	370	-7.59	0.05	—	0.05	-53.0	-6.52	80.7	0.04	332	2.45	0.55
Cash at period end	64.7	222	210	184	158	133	120	104	88.9	159	141	259	240	235	209	184	403	378	342	314	279	245	261	677	578	556	525	501	440	228	154	514	229	241	243	288	252	159	217	254	597	80.2	140

Profitability

Quarterly · %

Operating margin -1283.5% Net margin -1503.0%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2014Q4	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
Operating margin	-874.2%	-672.6%	-448.5%	-497.2%	-196.1%	-179.5%	-593.6%	-398.8%	-410.4%	-876.4%	-563.5%	-695.2%	-737.7%	-1505.3%	-2421.1%	-1185.6%	-2994.8%	-1256.3%	-33137.5%	-2489.1%	-2486.9%	-24.3%	-9792.5%	85.8%	-2262.4%	3.6%	-3017.9%	-11279.9%	-4107.5%	25.8%	-1392.9%	-2686.8%	-5819.3%	-923.1%	-639.1%	-395.6%	-1759.0%	-877.8%	-2510.0%	-833.6%	-1379.0%	-918.1%	-1283.5%
Net margin	—	-776.0%	—	—	—	-803.6%	-610.4%	-430.4%	-453.3%	-1063.2%	-540.2%	-675.1%	-700.0%	-1361.2%	-2444.7%	-1269.2%	-2256.6%	-1578.1%	-26922.1%	-2772.1%	-3005.9%	-2.0%	-9153.3%	86.1%	-1836.7%	14.3%	-2604.8%	-7859.4%	-3302.8%	6.6%	-1450.3%	-2827.2%	-6366.1%	-1094.4%	-773.3%	-506.0%	-1940.5%	-1403.2%	-2784.8%	-716.8%	-2175.9%	-666.1%	-1503.0%

Returns & leverage

Quarterly · %

ROE -228.2% ROA -30.2% Debt ratio 80.8%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2014Q4	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
ROE	—	—	—	—	—	—	—	—	-638.3%	-103.6%	-106.5%	-62.8%	-81.0%	-61.9%	-71.7%	-58.8%	-38.0%	-49.4%	-55.0%	-68.2%	-57.3%	-44.1%	-52.9%	67.5%	78.3%	78.5%	83.8%	-20.4%	-24.8%	-23.7%	-32.8%	-44.5%	-66.2%	-90.2%	-106.1%	-126.4%	-147.6%	-238.5%	-241.2%	-427.5%	-165.3%	-207.1%	-228.2%
ROA	—	—	—	—	—	—	—	—	-90.0%	-39.6%	-43.0%	-33.0%	-42.3%	-34.5%	-40.0%	-36.7%	-27.8%	-34.4%	-36.4%	-42.5%	-40.3%	-31.7%	-35.6%	51.9%	57.0%	57.3%	57.9%	-15.4%	-17.8%	-16.8%	-22.7%	-22.7%	-30.3%	-40.1%	-42.4%	-34.0%	-31.6%	-34.5%	-31.6%	-30.3%	-30.6%	-28.8%	-30.2%
Debt ratio	—	51.3%	—	—	—	66.6%	73.0%	82.7%	85.9%	57.4%	47.8%	29.2%	28.9%	34.4%	41.6%	47.8%	25.7%	28.0%	28.8%	31.1%	35.0%	28.4%	37.1%	19.2%	23.7%	26.4%	27.9%	30.6%	34.0%	32.5%	34.6%	62.5%	69.2%	75.0%	80.9%	86.7%	91.4%	101.2%	94.4%	100.7%	74.3%	75.9%	80.8%

EPS

Quarterly · US$

EPS US$-0.85

Show table：EPS

Item	2014Q4	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-3.11	—	-0.96	-1.21	-0.01	-0.91	8.51	-0.79	0.17	-1.00	-0.84	-1.02	0.15	-1.63	-1.44	-1.88	-1.53	-1.36	-1.16	-0.91	-1.50	-0.82	-0.69	-1.38	-0.56	-0.85

Revenue & profit

Year-to-date · In mn (USD)

Revenue 3.56 mn Net income -53.5 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 779 mn Total liabilities 629 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -38.2 mn Investing 98.6 mn Financing 0.55 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -1283.5% Net margin -1503.0%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -228.2% ROA -30.2% Debt ratio 80.8%

EPS

Year-to-date · US$

EPS US$-0.85

Revenue & profit

Annual · In mn (USD)

Revenue 16.1 mn Net income -199 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	25.1	13.1	11.3	7.28	37.5	524	106	15.8	27.1	16.1
Operating income	-72.0	-71.3	-88.2	-121	-125	311	-143	-283	-184	-185
Net income	—	-79.3	-83.3	-124	-125	330	-127	-308	-240	-199

Balance sheet

Annual · In mn (USD)

Total assets 825 mn Total liabilities 626 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	144	163	237	384	259	628	477	652	390	656
Total assets	190	210	274	449	340	809	705	832	557	825
Current liabilities	22.7	19.2	20.0	31.6	27.3	36.8	75.9	73.7	40.0	62.9
Total liabilities	127	120	94.3	126	96.5	213	229	624	563	626
Equity	63.6	89.4	180	323	244	596	476	208	-6.75	199

Cash flow

Annual · In mn (USD)

Operating -178 mn Investing -322 mn Financing 415 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-72.2	-64.3	-76.0	-98.7	-135	288	-145	-146	-183	-178
Investing	-17.2	-5.58	-4.24	-6.65	-9.48	-67.4	-183	-206	163	-322
Financing	2.44	90.1	158	249	7.44	94.9	1.45	363	—	415
Cash at period end	133	159	235	378	245	556	228	241	159	80.2

Profitability

Annual · %

Operating margin -1151.4% Net margin -1236.0%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	-286.7%	-544.3%	-781.9%	-1663.8%	-334.3%	59.3%	-134.4%	-1785.5%	-679.6%	-1151.4%
Net margin	—	-604.7%	-738.3%	-1705.8%	-333.3%	62.9%	-119.1%	-1947.1%	-883.4%	-1236.0%

Returns & leverage

Annual · %

ROE -207.1% ROA -28.8% Debt ratio 75.9%

Show table：Returns & leverage

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	—	-103.6%	-61.9%	-49.4%	-44.1%	78.5%	-23.7%	-90.2%	-238.5%	-207.1%
ROA	—	-39.6%	-34.5%	-34.4%	-31.7%	57.3%	-16.8%	-40.1%	-34.5%	-28.8%
Debt ratio	66.6%	57.4%	34.4%	28.0%	28.4%	26.4%	32.5%	75.0%	101.2%	75.9%

EPS

Annual · US$

EPS US$-3.45

Show table：EPS

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	—	6.98	-2.71	-6.48	-4.93	-3.45

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read uniQure N.V. (QURE) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.